ModivCare Statistics
Total Valuation
ModivCare has a market cap or net worth of $74.13 million. The enterprise value is $1.29 billion.
Important Dates
The next estimated earnings date is Thursday, February 20, 2025, after market close.
| Earnings Date | Feb 20, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ModivCare has 14.28 million shares outstanding. The number of shares has increased by 0.40% in one year.
| Current Share Class | 14.28M |
| Shares Outstanding | 14.28M |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 1.25% |
| Owned by Institutions (%) | 78.37% |
| Float | 9.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.48 |
| PS Ratio | 0.03 |
| Forward PS | 0.02 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 3.59 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.46 |
| EV / EBITDA | 9.84 |
| EV / EBIT | 54.73 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.80
| Current Ratio | 0.80 |
| Quick Ratio | 0.73 |
| Debt / Equity | n/a |
| Debt / EBITDA | 8.81 |
| Debt / FCF | n/a |
| Interest Coverage | 0.28 |
Financial Efficiency
Return on equity (ROE) is -258.05% and return on invested capital (ROIC) is 1.17%.
| Return on Equity (ROE) | -258.05% |
| Return on Assets (ROA) | 0.86% |
| Return on Capital (ROIC) | 1.17% |
| Revenue Per Employee | $131,491 |
| Profits Per Employee | -$8,634 |
| Employee Count | 21,200 |
| Asset Turnover | 1.63 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.01M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -87.36% in the last 52 weeks. The beta is 0.62, so ModivCare's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | -87.36% |
| 50-Day Moving Average | 13.65 |
| 200-Day Moving Average | 20.39 |
| Relative Strength Index (RSI) | 26.88 |
| Average Volume (20 Days) | 651,012 |
Short Selling Information
The latest short interest is 1.02 million, so 7.15% of the outstanding shares have been sold short.
| Short Interest | 1.02M |
| Short Previous Month | 644,268 |
| Short % of Shares Out | 7.15% |
| Short % of Float | 10.61% |
| Short Ratio (days to cover) | 4.32 |
Income Statement
In the last 12 months, ModivCare had revenue of $2.79 billion and -$183.04 million in losses. Loss per share was -$12.88.
| Revenue | 2.79B |
| Gross Profit | 432.54M |
| Operating Income | 23.54M |
| Pretax Income | -153.34M |
| Net Income | -183.04M |
| EBITDA | 130.92M |
| EBIT | 23.54M |
| Loss Per Share | -$12.88 |
Full Income StatementBalance Sheet
The company has $48.34 million in cash and $1.26 billion in debt, giving a net cash position of -$1.21 billion or -$84.99 per share.
| Cash & Cash Equivalents | 48.34M |
| Total Debt | 1.26B |
| Net Cash | -1.21B |
| Net Cash Per Share | -$84.99 |
| Equity (Book Value) | -17.00M |
| Book Value Per Share | -1.19 |
| Working Capital | -118.07M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$62.10 million and capital expenditures -$33.43 million, giving a free cash flow of -$95.52 million.
| Operating Cash Flow | -62.10M |
| Capital Expenditures | -33.43M |
| Free Cash Flow | -95.52M |
| FCF Per Share | -$6.69 |
Full Cash Flow StatementMargins
Gross margin is 15.52%, with operating and profit margins of 0.84% and -6.57%.
| Gross Margin | 15.52% |
| Operating Margin | 0.84% |
| Pretax Margin | -6.64% |
| Profit Margin | -6.57% |
| EBITDA Margin | 4.70% |
| EBIT Margin | 0.84% |
| FCF Margin | n/a |
Dividends & Yields
ModivCare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.40% |
| Shareholder Yield | -0.40% |
| Earnings Yield | -246.91% |
| FCF Yield | -128.85% |
Dividend DetailsAnalyst Forecast
The average price target for ModivCare is $18.20, which is 250.67% higher than the current price. The consensus rating is "Buy".
| Price Target | $18.20 |
| Price Target Difference | 250.67% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ModivCare has an Altman Z-Score of 1.64 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.64 |
| Piotroski F-Score | 4 |